Pharmacogenomics and pediatric drug development: science and political power. A narrative review

2024-9-13

Pharmacotherapeutic options for the treatment of hypertension in pregnancy

2024-9-3

Pharmacological management of chronic lymphocytic leukemia: current and emerging therapies

2024-8-30

Talazoparib for the treatment of prostate cancer

2024-8-29

Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer

2024-8-28

What are the future prospects for polycythemia vera pharmacotherapies for patients with hydroxyurea resistance?

2024-8-22

Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review

2024-8-21

Pharmacotherapy for cervical cancer: current standard of care and new perspectives

2024-8-20

Exploring Odevixibat’s efficacy in alagille syndrome: insights from recent clinical trials and IBAT Inhibitor Experiences

2024-8-19

The potential of Bruton’s tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological disease

2024-8-19

Factor VIII stimulants and other novel therapies for the treatment of von Willebrand disease: what’s new on the horizon?

2024-8-18

Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisons

2024-8-18

New and developing first line pharmacotherapies for treating non-hodgkin lymphoma

2024-8-17

New pharmaceutical-based strategies that foster the development and promulgation of globally effective medical countermeasures for radiation exposure injuries

2024-8-17

Cardio-reno-vascular protection in type 2 diabetes mellitus: new insights into pharmacotherapeutic management

2024-8-16

Pharmacotherapy for focal epilepsy: how close are we to a cure?

2024-8-14

Evaluation of infectious morbidity due to BTK inhibitors in indolent B-cell lymphomas: latest research findings and systematic analysis

2024-8-13

The impact of approved anti-obesity medications on osteoarthritis

2024-8-12

Ospemifene and vulvovaginal atrophy: an update of the clinical profile for post-menopausal women

2024-8-12

Evaluation of prescribing patterns of switching to and add-on lemborexant in patients treated with hypnotic medication: a nationwide claims database study in Japan

2024-8-12

Evaluating the safety and efficacy of seladelpar for adults with primary biliary cholangitis

2024-8-11

Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy

2024-8-8

Reshaping respiratory care: potential advances in inhaled pharmacotherapy in asthma

2024-8-8

The evolving landscape of polycythemia vera therapies

2024-8-6

Milvexian: evaluating the factor XIa inhibitor for the treatment of acute coronary syndrome

2024-7-29

Cytokine release syndrome after CAR T-cell therapy for B-cell acute lymphoblastic leukemia in children and young adolescents: storms make trees take deeper roots

2024-7-23

An update on pharmacotherapy for fungal infections in allogeneic stem cell transplant recipients

2024-7-23

Clinical challenges and considerations in pharmacotherapy of osteoporosis due to menopause

2024-7-23

An update on the use of ‘biotics’ in pediatric infectious gastroenteritis

2024-7-23

Pharmacotherapy for CD55 deficiency with CHAPLE disease: how close are we to a cure?

2024-7-23

Advances in the pharmacological management of bronchopulmonary dysplasia: an update of the literature

2024-7-23

Considerations when treating influenza infections with oseltamivir

2024-7-12

A spotlight on using HIF-PH inhibitors in renal anemia

2024-7-12

Advances in pharmacotherapy for sickle cell disease: what is the current state of play?

2024-7-8

The current state-of-the-art in pharmacotherapy for pulmonary sarcoidosis

2024-7-8

Fezolinetant: a novel nonhormonal therapy for vasomotor symptoms due to menopause

2024-7-2

The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic stroke

2024-7-2

PSMA-based therapeutics for prostate cancer

2024-7-2

Advances with janus kinase inhibitors for the treatment of myeloproliferative neoplasms: an update of the literature

2024-7-2

Examining linaclotide for the treatment of chronic idiopathic constipation

2024-7-2

Developments in conservative treatment for BCG-unresponsive non-muscle invasive bladder cancer

2024-7-2

What is the impact of anemia pharmacotherapy on chronic kidney disease progression?

2024-7-2

An update on the pharmacological management of acute respiratory distress syndrome

2024-6-28

Recent advances in JAK2 inhibition for the treatment of myelofibrosis

2024-6-26

Evaluating the safety and efficacy of vadadustat for the treatment of anemia associated with chronic kidney disease

2024-6-12

A bitter pill to swallow: adjustments to oral contraceptive pill use in polycystic ovary syndrome

2024-6-12

Treating influenza with neuraminidase inhibitors: an update of the literature

2024-6-12

Evaluating bexicaserin for the treatment of Developmental Epileptic Encephalopathies

2024-6-12

Perspectives on the current pharmacological strategies for chronic and atrophic gastritis: can more be done?

2024-6-12

Can we effectively manage chronic kidney disease with a precision-based pharmacotherapy plan? Where are we?

2024-6-12